Described herein are pharmaceutical packaging systems which reduce oxidative degradation of morphine, hydromorphone, promethazine and various oxygen-sensitive medicines, this sort of units which include a syringe with the oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with very small permeability to oxygen and comp